Agency Business briefs: August 2012

Share this article:
Ane Jones
Ane Jones

Publicis is merging a DTC advertising powerhouse, Kaplan Thaler, with its Publicis New York. The agencies' healthcare business will be unaffected by the merger, which will see Publicis New York's 400-odd employees, formerly headquartered in Herald Square, move into Kaplan Thaler's Midtown offices. The combined agency will be called Publicis Kaplan Thaler.

Omnicom specialty agency BioLumina promoted Ane Jones to president from managing director. Jones is now responsible for the day-to-day operations of BioLumina, building on her experience running the account side and her ability to attract new business.

Double Helix, a healthcare consultancy that operates across three continents, was bought by Interpublic Group's McCann Health. The formerly independent firm offers primary market research and market access consulting. In an e-mail to MM&M, John Cahill, CEO of McCann Health, said those two areas “have increased in importance worldwide” and that McCann Health “wanted to boost dramatically our global capabilities in these areas.” Headquartered in London, Double Helix also has offices in the US (New York and Philadelphia) and Singapore.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?